Corporate philanthropy can play a powerful role in addressing pervasive public health problems—a look at three effective practices from the Merck Childhood Asthma Network.
For one leading health funder, program-related investments promise to help underserved populations.
City officials under Mayor Michael Bloomberg made advances in public health that were important but hardly unique.
Efforts to bring promising health care interventions to resource-constrained regions of the world often falter because entrepreneurs underestimate the array of obstacles that loom in their path.
With a sustainable program structure, skilled advocacy, and targeted technical assistance, Evidence Action helped pull off the world’s largest one-day deworming event.
By predicting vulnerability, biological science can help families, communities, clinicians, and policymakers develop more effective responses to a troubling health challenge.
Investments that can dramatically improve kindergarten readiness for at-risk children.
How the Belgian Red Cross is using scientific evidence to make its services more effective—and cost-effective.
Why we need strong public-private partnerships in health care and beyond.
We must create new channels for collaboration, new strategies for investment, and a coordinated approach as we look to achieve and pay for the new global agenda.